Advertisement

Topics

Search Results for "Tailand Swine Influenza Vaccine Market"

14:18 EDT 29th June 2016 | BioPortfolio

Matching Channels

Matching News

Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four ...

The traditional seasonal influenza vaccine is a trivalent formula consisting of two strains of influenza A viruses and a single strain of influenza B virus. Read more...

Human Swine Flu (H1N1) and Novel Influenza Pandemics

Vaccine experts and public health officials met at the Academy to discuss the latest about the outbreak. A complete eBriefing is now available, including video interviews with the CDC's Michael Shaw a...

H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure

GSK announced today that the U.S. Food and Drug Administration (FDA) has approved its pandemic Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (also referred to as Q-Pan H5N1 influenza vaccin...

ACIP Nixes Nasal Spray Influenza Vaccine for Next Season

The CDC's ACIP has recommended that live attenuated influenza vaccine, the nasal spray influenza vaccine, should not be used because it was ineffective during the last three influenza seasons. Meds...

Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine

GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic v...

CDC's ACIP recommends against 'nasal spray' flu vaccine for next season

Michael JohnsenACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine or recombinant influenza vaccine, for everyone 6 months and older. read more

ACIP: Flu vaccine 59% effective to date

The CDC’s Advisory Committee for Immunization Practices continued to recommend that all people aged 6 months and older be vaccinated annually against influenza during its recent meeting and also ame...

FDA Approves GlaxoSmithKline’s four-strain seasonal influenza vaccine for use in the US

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and...

Matching PubMed Articles

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.

Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...

Influenza B vaccine lineage selection-An optimized trivalent vaccine.

Epidemics of seasonal influenza viruses cause considerable morbidity and mortality each year. Various types and subtypes of influenza circulate in humans and evolve continuously such that individuals ...

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.

The seasonal influenza vaccine is currently the most effective preventive modality against influenza infection. Nasopharyngeal samples of vaccinated and non-vaccinated patients presenting with Influen...

Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom.

To investigate reasons underlying the low uptake of the influenza A H1N1v vaccination in the UK during the 2009/10 pandemic.

Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Influenza A virus in swine (IAV-S) is one of the most important infectious disease agents of swine in North America. In addition to the economic burden of IAV-S to the swine industry, the zoonotic pot...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement